Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(23):1910-1917; doi:10.1093/jnci/92.23.1910
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Stattin, P.
Right arrow Articles by Kaaks, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stattin, P.
Right arrow Articles by Kaaks, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 23, 1910-1917, December 6, 2000
© 2000 Oxford University Press

Plasma Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-Binding Proteins, and Prostate Cancer Risk: a Prospective Study

Pär Stattin, Annika Bylund, Sabina Rinaldi, Carine Biessy, Henri Déchaud, Ulf-Håkan Stenman, Lars Egevad, Elio Riboli, Göran Hallmans, Rudolf Kaaks

Affiliations of authors: P. Stattin (Department of Urology and Andrology), A. Bylund (Department of Geriatrics), G. Hallmans (Department of Public Health and Clinical Medicine), Umeå University Hospital, Sweden; S. Rinaldi, C. Biessy, E. Riboli, R. Kaaks, International Agency for Research on Cancer, Lyon, France; H. Déchaud, Central Laboratory for Biochemistry, Hôpital de l'Antiquaille, Lyon; U.-H. Stenman, Department of Clinical Chemistry, Helsinki University Central Hospital, Finland; L. Egevad, Department of Pathology, Karolinska Hospital, Stockholm, Sweden.

Correspondence to: Pär Stattin, M.D., Ph.D., Department of Urology and Andrology, Umeå University Hospital, 901 85 Umeå, Sweden (e-mail: par. stattin{at}urologi.umu.se).

Background: Recent studies have suggested that men with elevated plasma levels of insulin-like growth factor-I (IGF-I) may have an increased risk of prostate cancer. Furthermore, IGF-binding proteins (IGFBPs) and insulin can modulate the activity of IGF-I. In this study, we sought to determine the role of IGF-I as well as IGFBPs-1, -2, and -3 and insulin as possible etiologic factors for prostate cancer. Methods: We conducted a nested case–control study within the Northern Sweden Health and Disease Cohort Study. We measured levels of IGF-I, IGFBP-1, IGFBP-2, IGFBP-3, and insulin in plasma samples from 149 men who had a diagnosis of prostate cancer between 1 month and 10 years after blood collection and among 298 control men. All statistical tests are two-sided. Results: Case subjects had statistically significantly higher mean levels of IGF-I than control subjects (229 ng/mL; 95% confidence interval [CI] = 218–240 ng/mL] versus 214 ng/mL [95% CI = 208–221 ng/mL]; P = .02) and IGFBP-3 (2611 ng/mL [95% CI = 2518–2704 ng/mL] versus 2498 ng/mL [95% CI = 2437–2560 ng/mL]; P = .04). Conditional logistic regression analyses showed increases in prostate cancer risk with rising levels of IGF-I (Pfor trend = .02) and IGFBP-3 (Pfor trend = .03). In case subjects younger than 59 years at the time of blood collection, the risk associated with increased IGF-I was higher (Pfor trend = .01), whereas the risk associated with increased IGFBP-3 was lower (Pfor trend = .44) than the corresponding risks in the full cohort. Prostate cancer risk was not associated with levels of IGFBP-1, IGFBP-2, or insulin. Conclusions: Prostate cancer risk is increased in men with elevated plasma IGF-I. This association was particularly strong in younger men in this study, suggesting that circulating IGF-I may be specifically involved in the early pathogenesis of prostate cancer.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Anzo, L. J. Cobb, D. L. Hwang, H. Mehta, J. W. Said, S. Yakar, D. LeRoith, and P. Cohen
Targeted Deletion of Hepatic Igf1 in TRAMP Mice Leads to Dramatic Alterations in the Circulating Insulin-Like Growth Factor Axis but Does Not Reduce Tumor Progression
Cancer Res., May 1, 2008; 68(9): 3342 - 3349.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Kobayashi, R. J. Barnard, J. Said, J. Hong-Gonzalez, D. M. Corman, M. Ku, N. B. Doan, D. Gui, D. Elashoff, P. Cohen, et al.
Effect of Low-Fat Diet on Development of Prostate Cancer and Akt Phosphorylation in the Hi-Myc Transgenic Mouse Model
Cancer Res., April 15, 2008; 68(8): 3066 - 3073.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Darbinian, A. M. Ferrara, S. K. Van Den Eeden, C. P. Quesenberry Jr., B. Fireman, and L. A. Habel
Glycemic Status and Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 628 - 635.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. Wang, R. M. Luque, R. D. Kineman, V. H. Ray, K. T. Christov, D. D. Lantvit, T. Shirai, S. Hedayat, T. G. Unterman, M. C. Bosland, et al.
Disruption of Growth Hormone Signaling Retards Prostate Carcinogenesis in the Probasin/TAg Rat
Endocrinology, March 1, 2008; 149(3): 1366 - 1376.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. J. Borugian, J. J. Spinelli, Z. Sun, L. N. Kolonel, I. Oakley-Girvan, M. D. Pollak, A. S. Whittemore, A. H. Wu, and R. P. Gallagher
Prostate Cancer Risk in Relation to Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3: A Prospective Multiethnic Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 252 - 254.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. J. Borugian, J. J. Spinelli, Z. Sun, L. N. Kolonel, I. Oakley-Girvan, M. D. Pollak, A. S. Whittemore, A. H. Wu, and R. P. Gallagher
Prediagnostic C-Peptide and Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2164 - 2165.
[Full Text] [PDF]


Home page
Ann OncolHome page
N Travier, M Jeffreys, N Brewer, C. Wright, C. Cunningham, J Hornell, and N Pearce
Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study
Ann. Onc., August 1, 2007; 18(8): 1414 - 1419.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. E. Allen, T. J. Key, P. N. Appleby, R. C. Travis, A. W. Roddam, S. Rinaldi, L. Egevad, S. Rohrmann, J. Linseisen, T. Pischon, et al.
Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1121 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Epidemiol RevHome page
S. J. Freedland and E. A. Platz
Obesity and Prostate Cancer: Making Sense out of Apparently Conflicting Data
Epidemiol. Rev., May 3, 2007; (2007) mxm006v1.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Schaffer, A. Koushik, H. Trottier, E. Duarte-Franco, N. Mansour, J. Arseneau, D. Provencher, L. Gilbert, W. Gotlieb, A. Ferenczy, et al.
Insulin-like Growth Factor-I and Risk of High-Grade Cervical Intraepithelial Neoplasia
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 716 - 722.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
P. H M Peeters, A. Lukanova, N. Allen, F. Berrino, T. Key, L. Dossus, S. Rinaldi, C. H van Gils, H B. Bueno-de-Mesquita, H. Boeing, et al.
Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC)
Endocr. Relat. Cancer, March 1, 2007; 14(1): 81 - 90.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. L. Ahmed, W. Thomas, and K. H. Schmitz
Interactions between Insulin, Body Fat, and Insulin-Like Growth Factor Axis Proteins
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 593 - 597.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. Stattin, O. Bjor, P. Ferrari, A. Lukanova, P. Lenner, B. Lindahl, G. Hallmans, and R. Kaaks
Prospective Study of Hyperglycemia and Cancer Risk
Diabetes Care, March 1, 2007; 30(3): 561 - 567.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Endocr. Rev., February 1, 2007; 28(1): 20 - 47.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Chen, R. Freeman, L. F. Voigt, A. Fitzpatrick, S. R. Plymate, and N. S. Weiss
Prostate Cancer Risk in Relation to Selected Genetic Polymorphisms in Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-3, and Insulin-like Growth Factor-I Receptor
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2461 - 2466.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. S. Kasper and E. Giovannucci
A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2056 - 2062.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Z. Gong, M. L. Neuhouser, P. J. Goodman, D. Albanes, C. Chi, A. W. Hsing, S. M. Lippman, E. A. Platz, M. N. Pollak, I. M. Thompson, et al.
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1977 - 1983.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S Rinaldi, P H M Peeters, F Berrino, L Dossus, C Biessy, A Olsen, A Tjonneland, K Overvad, F Clavel-Chapelon, M C Boutron-Ruault, et al.
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC).
Endocr. Relat. Cancer, June 1, 2006; 13(2): 593 - 605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Le, J. T. Arnold, K. K. McFann, and M. R. Blackman
DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E952 - E960.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kawada, H. Inoue, T. Masuda, and D. Ikeda
Insulin-like Growth Factor I Secreted from Prostate Stromal Cells Mediates Tumor-Stromal Cell Interactions of Prostate Cancer.
Cancer Res., April 15, 2006; 66(8): 4419 - 4425.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. Wang, G. S. Prins, K. T. Coschigano, J. J. Kopchick, J. E. Green, V. H. Ray, S. Hedayat, K. T. Christov, T. G. Unterman, and S. M. Swanson
Disruption of Growth Hormone Signaling Retards Early Stages of Prostate Carcinogenesis in the C3(1)/T Antigen Mouse
Endocrinology, December 1, 2005; 146(12): 5188 - 5196.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
E. Giovannucci
Sun Exposure May Confound Physical Activity-Prostate Cancer Association--Reply
Arch Intern Med, November 28, 2005; 165(21): 2539 - 2540.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. J. Freedland, W. J. Aronson, B. Trock, P. Cohen, C. J. Kane, C. L. Amling, J. C. Presti Jr., M. K. Terris, and for the Shared Equal Access Regional Cancer Hospit
Racial Differences in Prognostic Value of Adult Height for Biochemical Progression Following Radical Prostatectomy
Clin. Cancer Res., November 1, 2005; 11(21): 7735 - 7742.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. Canzian, J. D. McKay, R. J. Cleveland, L. Dossus, C. Biessy, C. Boillot, S. Rinaldi, M. Llewellyn, V. Chajes, F. Clavel-Chapelon, et al.
Genetic Variation in the Growth Hormone Synthesis Pathway in Relation to Circulating Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Breast Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2316 - 2325.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. Meyer, P. Galan, P. Douville, I. Bairati, P. Kegle, S. Bertrais, S. Czernichow, and S. Hercberg
A Prospective Study of the Insulin-Like Growth Factor Axis in Relation with Prostate Cancer in the SU.VI.MAX Trial
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2269 - 2272.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Wang, D. H. Catlin, B. Starcevic, D. Heber, C. Ambler, N. Berman, G. Lucas, A. Leung, K. Schramm, P. W. N. Lee, et al.
Low-Fat High-Fiber Diet Decreased Serum and Urine Androgens in Men
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3550 - 3559.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. K. Nam, J. Trachtenberg, M. A.S. Jewett, A. Toi, A. Evans, M. Emami, S. A. Narod, and M. Pollak
Serum Insulin-Like Growth Factor-I Levels and Prostatic Intraepithelial Neoplasia: A Clue to the Relationship Between IGF-I Physiology and Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1270 - 1273.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Serrano, L. Baglietto, H. Johansson, F. Mariette, R. Torrisi, M. Onetto, M. Paganuzzi, and A. Decensi
Effect of the Synthetic Retinoid Fenretinide on Circulating Free Prostate-Specific Antigen, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 Levels in Men with Superficial Bladder Cancer
Clin. Cancer Res., March 1, 2005; 11(5): 2083 - 2088.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. M. Schildkraut, W. Demark-Wahnefried, R. M. Wenham, J. Grubber, A. S. Jeffreys, S. C. Grambow, J. R. Marks, P. G. Moorman, C. Hoyo, S. Ali, et al.
IGF1 (CA)19 Repeat and IGFBP3 -202 A/C Genotypes and the Risk of Prostate Cancer in Black and White Men
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 403 - 408.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
C. Rodriguez, A. V. Patel, A. M. Mondul, E. J. Jacobs, M. J. Thun, and E. E. Calle
Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men
Am. J. Epidemiol., January 15, 2005; 161(2): 147 - 152.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Rinaldi, R. Kaaks, A. Zeleniuch-Jacquotte, A. A. Arslan, R. E. Shore, K. L. Koenig, L. Dossus, E. Riboli, P. Stattin, A. Lukanova, et al.
Insulin-Like Growth Factor-I, IGF Binding Protein-3, and Breast Cancer in Young Women: A Comparison of Risk Estimates Using Different Peptide Assays
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 48 - 52.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. W. Voskuil, A. Vrieling, L. J. van't Veer, E. Kampman, and M. A. Rookus
The Insulin-like Growth Factor System in Cancer Prevention: Potential of Dietary Intervention Strategies
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 195 - 203.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. V. Patel, C. Rodriguez, E. J. Jacobs, L. Solomon, M. J. Thun, and E. E. Calle
Recreational Physical Activity and Risk of Prostate Cancer in a Large Cohort of U.S. Men
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 275 - 279.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Laukkanen, D. E. Laaksonen, L. Niskanen, E. Pukkala, A. Hakkarainen, and J. T. Salonen
Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study
Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1646 - 1650.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. M. J. L. Janssen, M. F. Wildhagen, K. Ito, B. G. Blijenberg, R. H. N. van Schaik, M. J. Roobol, H. A. P. Pols, S. W. J. Lamberts, and F. H. Schroder
Circulating Free Insulin-Like Growth Factor (IGF)-I , Total IGF-I, and IGF Binding Protein-3 Levels Do Not Predict the Future Risk to Develop Prostate Cancer: Results of a Case-Control Study Involving 201 Patients within a Population-Based Screening with a 4-Year Interval
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4391 - 4396.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Stattin, S. Rinaldi, C. Biessy, U.-H. Stenman, G. Hallmans, and R. Kaaks
High Levels of Circulating Insulin-Like Growth Factor-I Increase Prostate Cancer Risk: A Prospective Study in a Population-Based Nonscreened Cohort
J. Clin. Oncol., August 1, 2004; 22(15): 3104 - 3112.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Wu, H. Zhao, K.-A. Do, M. M. Johnson, Q. Dong, W. K. Hong, and M. R. Spitz
Serum Levels of Insulin Growth Factor (IGF-I) and IGF-Binding Protein Predict Risk of Second Primary Tumors in Patients with Head and Neck Cancer
Clin. Cancer Res., June 15, 2004; 10(12): 3988 - 3995.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Peng, P. J. Malloy, and D. Feldman
Identification of a Functional Vitamin D Response Element in the Human Insulin-Like Growth Factor Binding Protein-3 Promoter
Mol. Endocrinol., May 1, 2004; 18(5): 1109 - 1119.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Wolk, S. C. Larsson, B. Vessby, A. Wolk, and K. Brismar
Metabolic, Anthropometric, and Nutritional Factors as Predictors of Circulating Insulin-Like Growth Factor Binding Protein-1 Levels in Middle-Aged and Elderly Men
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1879 - 1884.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P.-S. Leung, W. J. Aronson, T. H. Ngo, L. A. Golding, and R. J. Barnard
Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro
J Appl Physiol, February 1, 2004; 96(2): 450 - 454.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
Y. Daaka
G Proteins in Cancer: The Prostate Cancer Paradigm
Sci. Signal., January 20, 2004; 2004(216): re2 - re2.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Gunnell, S. E. Oliver, J. L. Donovan, T. J. Peters, D. Gillatt, R. Persad, F. C. Hamdy, D. E. Neal, and J. M. P. Holly
Do Height-Related Variations in Insulin-Like Growth Factors Underlie the Associations of Stature with Adult Chronic Disease?
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 213 - 218.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. P. Singh, G. Sharma, G. U. Mallikarjuna, S. Dhanalakshmi, C. Agarwal, and R. Agarwal
In Vivo Suppression of Hormone-Refractory Prostate Cancer Growth by Inositol Hexaphosphate: Induction of Insulin-Like Growth Factor Binding Protein-3 and Inhibition of Vascular Endothelial Growth Factor
Clin. Cancer Res., January 1, 2004; 10(1): 244 - 250.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. K. Nam, W. W. Zhang, J. Trachtenberg, M. A. S. Jewett, M. Emami, D. Vesprini, W. Chu, M. Ho, J. Sweet, A. Evans, et al.
Comprehensive Assessment of Candidate Genes and Serological Markers for the Detection of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1429 - 1437.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Song, S. C. Cornelius, M. Reiss, and D. Danielpour
Insulin-like Growth Factor-I Inhibits Transcriptional Responses of Transforming Growth Factor-{beta} by Phosphatidylinositol 3-Kinase/Akt-dependent Suppression of the Activation of Smad3 but Not Smad2
J. Biol. Chem., October 3, 2003; 278(40): 38342 - 38351.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. Stattin and R. Kaaks
Re: Insulin Resistance and Prostate Cancer Risk
J Natl Cancer Inst, July 16, 2003; 95(14): 1086 - 1087.
[Full Text] [PDF]


Home page
Cancer Res.Home page
K. Woodson, J. A. Tangrea, M. Pollak, T. D. Copeland, P. R. Taylor, J. Virtamo, and D. Albanes
Serum Insulin-like Growth Factor I: Tumor Marker or Etiologic Factor? A Prospective Study of Prostate Cancer among Finnish Men
Cancer Res., July 15, 2003; 63(14): 3991 - 3994.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. H. Ngo, R. J. Barnard, P. Cohen, S. Freedland, C. Tran, F. deGregorio, Y. I. Elshimali, D. Heber, and W. J. Aronson
Effect of Isocaloric Low-fat Diet on Human LAPC-4 Prostate Cancer Xenografts in Severe Combined Immunodeficient Mice and the Insulin-like Growth Factor Axis
Clin. Cancer Res., July 1, 2003; 9(7): 2734 - 2743.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. H. Ngo, R. J. Barnard, P.-S. Leung, P. Cohen, and W. J. Aronson
Insulin-Like Growth Factor I (IGF-I) and IGF Binding Protein-1 Modulate Prostate Cancer Cell Growth and Apoptosis: Possible Mediators for the Effects of Diet and Exercise on Cancer Cell Survival
Endocrinology, June 1, 2003; 144(6): 2319 - 2324.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
R. O. Roberts, D. J. Jacobson, C. J. Girman, T. Rhodes, G. G. Klee, M. M. Lieber, and S. J. Jacobsen
Insulin-like Growth Factor I, Insulin-like Growth Factor Binding Protein 3, and Urologic Measures of Benign Prostatic Hyperplasia
Am. J. Epidemiol., May 1, 2003; 157(9): 784 - 791.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. E. Paradis, P. W. Kantoff, E. Giovannucci, M. J. Stampfer, and J. Ma
Association between the Met326Ile Polymorphism of the p85{alpha} Regulatory Subunit of Phosphatidylinositol 3-Kinase and Prostate Cancer Risk: A Prospective Study
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 172 - 173.
[Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. D. Burroughs, J. Oh, J. C. Barrett, and R. P. DiAugustine
Phosphatidylinositol 3-Kinase and Mek1/2 Are Necessary for Insulin-Like Growth Factor-I-Induced Vascular Endothelial Growth Factor Synthesis in Prostate Epithelial Cells: A Role for Hypoxia-Inducible Factor-1?
Mol. Cancer Res., February 1, 2003; 1(4): 312 - 322.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. A. Krajcik, N. D. Borofsky, S. Massardo, and N. Orentreich
Insulin-like Growth Factor I (IGF-I), IGF-binding Proteins, and Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1566 - 1573.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Yu, F. Jin, X.-O. Shu, B. D. L. Li, Q. Dai, J.-R. Cheng, H. J. Berkel, and W. Zheng
Insulin-like Growth Factors and Breast Cancer Risk in Chinese Women
Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 705 - 712.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. R. Kristal, J. H. Cohen, P. Qu, and J. L. Stanford
Associations of Energy, Fat, Calcium, and Vitamin D with Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 719 - 725.
[Abstract] [Full Text] [PDF]


Home page